CRCM
VC Fund
San Francisco, United States
CRCM is a venture capital firm.
- Total investments:
- 121
- Last investment:
- Lead investor:
- 9%
- Fund size:
- $66M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries CRCM invests in
Stages CRCM invests in
Countries CRCM invests in
Contacts
Investment Focus
Industry
- Software 23 (19%)
- Health Care 15 (12%)
- Biotechnology 14 (12%)
- E-Commerce 12 (10%)
- Artificial Intelligence 11 (9%)
Stage
- Seed 60 (50%)
- Series A 20 (17%)
- Funding Round 12 (10%)
- Pre-Seed 7 (6%)
- Series B 7 (6%)
Country
- United States 87 (72%)
- China 9 (7%)
- Canada 6 (5%)
- Mexico 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
CC Ya
Investment Associate
|
Investment Associate | Total investments: 0 | Find email | |
|
Private Private
Founder, Chief Investment Officer, General Partner & Managing Partner
|
Founder, Chief Investment Officer, General Partner & Managing Partner | Total investments: 0 | Find email | |
AL Lin
Business Development
|
Business Development | Total investments: 0 | Find email | |
Anh Le
Partner
|
Partner | Total investments: 0 | Find email | |
JS Ngo
CFO
|
CFO | Total investments: 0 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Paren
|
Accelerate the adoption of electric vehicles, delivering data solutions that ensure every journey is powered by trust, reliability and sustainability. | $3M / Seed / Oct 03, 2024 | |
Venteur
|
Venteur is the health insurance operating system designed to end "job lock" and return healthcare agency to the individual. Leveraging the ICHRA model, we enable employers to provide predictable, defined-contribution benefits while giving employees the freedom to choose and own their coverage.By balancing technology-driven scale withpeople-centric advocacy, we service the real-life needs of individuals navigating complex care. Venteur is on a mission to decouple health insurance from employment, building the reliable infrastructure for a personalized, portable healthcare future. | $7.6M / Seed / Aug 18, 2023 | |
ClearBlue Markets
|
ClearBlue Markets offers specialization in carbon sales, consulting, project development, solutions and services. | $8M / Series A / Mar 20, 2023 | |
Inso Biosciences
|
Inso Biosciences is an early-stage biotechnology company developing hardware platforms and tools for genomic sample handling. Our patented microfluidic technology, invented and developed at Cornell University, performs high-efficiency processing of cellular material, and we are exploring applications in long-read DNA extraction, multiomic sampleprocessing, and pathogen surveillance.To find out more, please visit our website: www.inso.bio To get in touch with us, please email: contact@inso.bio | $1.8M / Pre-Seed / Apr 01, 2022 | |
Yali Bio
|
Yali Biosciences is a food tech company that uses synthetic biology and genomics tools to make climate-smart, sustainable foods. | $3.9M / Seed / Feb 22, 2022 | |
Koda Health
|
Koda Health offers digital health tools and services focused on advance care planning and kidney care. The company provides a platform that guides patients through defining and documenting their medical care preferences for serious illness, and supports coordination for those with chronic kidney disease. It integrates with electronic medicalrecords (EMRs) using standards like HL7 FHIR to share patient directives securely. Koda Health also uses risk models to identify patients with complex health needs and connects them to patient advocate support. The company emphasizes user-friendly interfaces, video explainers, and interactive value identification to help individuals understand treatment options and communicate their wishes. | $3.5M / Seed / Feb 07, 2022 | |
|
Koda Health
|
Koda Health offers digital health tools and services focused on advance care planning and kidney care. The company provides a platform that guides patients through defining and documenting their medical care preferences for serious illness, and supports coordination for those with chronic kidney disease. It integrates with electronic medicalrecords (EMRs) using standards like HL7 FHIR to share patient directives securely. Koda Health also uses risk models to identify patients with complex health needs and connects them to patient advocate support. The company emphasizes user-friendly interfaces, video explainers, and interactive value identification to help individuals understand treatment options and communicate their wishes. | $3.5M / Seed / Feb 07, 2022 | |
|
TômTex Co
|
100% naturally bio-based material made from food waste | $1.2M / Pre-Seed / Jan 15, 2022 | |
|
Venteur
|
Venteur is the health insurance operating system designed to end "job lock" and return healthcare agency to the individual. Leveraging the ICHRA model, we enable employers to provide predictable, defined-contribution benefits while giving employees the freedom to choose and own their coverage.By balancing technology-driven scale withpeople-centric advocacy, we service the real-life needs of individuals navigating complex care. Venteur is on a mission to decouple health insurance from employment, building the reliable infrastructure for a personalized, portable healthcare future. | $120K / Pre-Seed / Sep 07, 2021 | |
Copper Cow Coffee
|
Copper Cow Coffee is a premium specialty Vietnamese Coffee Company based in Los Angeles. CCC supports sustainable agriculture in Vietnam and works to make specialty Vietnamese coffee more accessible in the US through modern design, innovative packaging, as well as socially and environmentally-conscious sourcing. | $8.5M / Series A / May 04, 2021 | |
| See all 121 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does CRCM invest in?
CRCM invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 121 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CRCM?
Public channels for CRCM include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CRCM?
The team at CRCM includes CC Ya (Investment Associate), Private Private (Founder, Chief Investment Officer, General Partner & Managing Partner) and AL Lin (Business Development), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
